Department of Internal Medicine, Texas Tech University Health Sciences Center, Amarillo, Texas, USA.
Department of Internal Medicine, Yale University, New Haven, Connecticut, USA.
J Cardiovasc Electrophysiol. 2021 Jun;32(6):1772-1777. doi: 10.1111/jce.15078. Epub 2021 May 16.
Atrioventricular nodal reentrant tachycardia (AVNRT) is the most common sustained supraventricular arrhythmias. An understanding of gender-related differences in AVNRT epidemiology, diagnosis, treatment, outcome, and complications can help guide a more effective diagnosis and treatment of the condition. The study aimed to perform a review of the available literature regarding all aspects of gender-related differences of AVNRT. We focused on all aspects of gender-related differences regarding AVNRT between men and women. A literature search was performed using Google Scholar, PubMed, Springer, Ovid, and Science Direct. Many investigations have demonstrated that the prevalence of AVNRT exhibited a twofold women-to-men predominance. The potential mechanism behind this difference due to sex hormones and autonomic tone. Despite being more common in women, there is a delay in offering and performing the first-line therapy (catheter ablation) compared to men. There were no significant gender-related discrepancies in patients who underwent ablation therapy for AVNRT, regarding the acute success rate of the procedure, long-term success rate, and recurrence of AVNRT. AVNRT is more common in women due to physiological factors such as sex hormones and autonomic tone. Catheter ablation is equally safe and efficacious in men and women; however, the time between the onset of symptoms and ablation is significantly prolonged in women. It is important for the medical community to be aware of this discrepancy and to strive to eliminate such disparities that are not related to patients' choices.
房室结折返性心动过速(AVNRT)是最常见的持续性室上性心律失常。了解 AVNRT 流行病学、诊断、治疗、预后和并发症方面的性别差异,可以帮助指导更有效地诊断和治疗该疾病。本研究旨在对有关 AVNRT 性别差异的所有方面的现有文献进行综述。我们专注于男女之间关于 AVNRT 的所有性别差异方面。使用 Google Scholar、PubMed、Springer、Ovid 和 Science Direct 进行了文献检索。许多研究表明,AVNRT 的患病率表现出女性是男性的两倍。这种差异的潜在机制是由于性激素和自主神经张力。尽管在女性中更为常见,但与男性相比,女性接受一线治疗(导管消融)的时间延迟。对于接受 AVNRT 消融治疗的患者,在手术的急性成功率、长期成功率和 AVNRT 复发方面,没有明显的性别差异。由于性激素和自主神经张力等生理因素,AVNRT 在女性中更为常见。导管消融在男性和女性中同样安全有效;然而,女性症状发作和消融之间的时间明显延长。医学界意识到这一差异并努力消除与患者选择无关的差异非常重要。